glycopyrrolate 0.2 MG in 1 ML Injection
- RxCUI
- 1731582
- RxNorm name
- glycopyrrolate 0.2 MG in 1 ML Injection
- Display name
- glycopyrrolate 0.2 MG in 1 ML Injection
- Full name
- glycopyrrolate 0.2 MG in 1 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:12
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glycopyrrolate | GLYCOPYRROLATE | Amneal Pharmaceuticals LLC | bbab4cf1-0441-4fc4-9de9-e4117fa19faa | 2026-07-07 | Warnings, Adverse reactions | 1731582 |
| Glycopyrrolate | GLYCOPYRROLATE | Piramal Critical Care Inc | 83d70378-011b-4ce3-e053-2991aa0a22be | 2026-06-23 | Warnings, Adverse reactions | 1731582 |
| Glycopyrrolate | GLYCOPYRROLATE | Cardinal Health 107, LLC | 65688bed-0d70-4b51-8301-1948b1deade1 | 2026-06-02 | Warnings, Adverse reactions | 1731582 |
| Glycopyrrolate | GLYCOPYRROLATE | Gland Pharma Limited | d670bd26-8a44-44be-90e1-107d4c380233 | 2026-04-28 | Warnings, Adverse reactions | 1731582 |
| Glycopyrrolate | GLYCOPYRROLATE | Sagent Pharmaceuticals | 55930f87-8964-43b1-b790-c1e6dd2602d2 | 2026-04-20 | Warnings, Adverse reactions | 1731582 |
| Glycopyrrolate | GLYCOPYRROLATE | Sandoz Inc | cb1ae370-ec4f-4114-9860-8f736f72b545 | 2026-04-01 | Warnings, Adverse reactions | 1731582 |
| Glycopyrrolate | GLYCOPYRROLATE | Lifestar Pharma LLC | 0f4a4b94-71e0-49ed-8f1e-c760e4dd3137 | 2026-03-25 | Warnings, Adverse reactions | 1731582 |
| Glycopyrrolate | GLYCOPYRROLATE | Accord Healthcare, Inc., | 871797f0-697a-4a29-a37b-d06219e8f266 | 2025-10-17 | Warnings, Adverse reactions | 1731582 |
| Glycopyrrolate | GLYCOPYRROLATE | Henry Schein, Inc. | 8b4d1798-c0a7-4661-99cd-1e9a23c16386 | 2025-10-16 | Warnings, Adverse reactions | 1731582 |
| GLYCOPYRROLATE | GLYCOPYRROLATE | ProPharma Distribution | 3edcc39d-0e29-4585-e063-6394a90ad512 | 2025-09-15 | Warnings, Adverse reactions | 1731582 |
| Glycopyrrolate | GLYCOPYRROLATE | Alembic Pharmaceuticals Inc. | 327f8a9e-7730-4f38-a7aa-fbddebddf173 | 2025-08-26 | Warnings, Adverse reactions | 1731582 |
| GLYRX-PF | GLYCOPYRROLATE | Exela Pharma Sciences, LLC | 2189f3f5-39dc-4e85-b7c6-9515ded59686 | 2025-07-23 | Warnings, Adverse reactions | 1731582 |
| Glycopyrrolate | GLYCOPYRROLATE | Caplin Steriles Limited | 765490fa-8378-40c8-9fa7-b0bfa2e1a0a9 | 2025-01-25 | Warnings, Adverse reactions | 1731582 |
| GLYCOPYRROLATE | GLYCOPYRROLATE | HF Acquisition Co LLC, DBA HealthFirst | 9a3a142c-daaf-79af-e053-2995a90a1c51 | 2025-01-08 | Warnings, Adverse reactions | 1731582 |
| Glycopyrrolate | GLYCOPYRROLATE | Fresenius Kabi USA, LLC | ccafb5c2-86dd-4bb2-883a-c13e3171227c | 2024-10-14 | Warnings, Adverse reactions | 1731582 |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Somerset Therapeutics, LLC | 48cfbd5a-b133-4720-9bd7-65296064ea3c | 2024-08-31 | Warnings, Adverse reactions | 1731582 |
| GLYCOPYRROLATE | GLYCOPYRROLATE | HF Acquisition Co LLC, DBA HealthFirst | 9be0ad4e-3efa-1a24-e053-2995a90a60d5 | 2024-02-22 | Warnings, Adverse reactions | 1731582 |
| Glycopyrrolate | GLYCOPYRROLATE | American Regent, Inc. | 62267afe-1a73-4623-984e-646db590ec5b | 2024-02-07 | Warnings, Adverse reactions | 1731582 |
| GLYCOPYRROLATE 1ML | GLYCOPYRROLATE | XIROMED LLC | 1bb2fa8a-3318-1e9a-2c79-8371bcae3d1c | 2023-10-23 | Warnings, Adverse reactions | 1731582 |
| Glycopyrrolate | GLYCOPYRROLATE | Fresenius Kabi USA, LLC | 250eeef7-b1a9-45e7-a927-7807232e10be | 2023-09-22 | Warnings, Adverse reactions | 1731582 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 8b4d1798-c0a7-4661-99cd-1e9a23c16386 | glycopyrrolate 0.2 MG in 1 ML Injection [PSN] · 1 ML glycopyrrolate 0.2 MG/ML Injection [SCD] · glycopyrrolate 0.2 MG per 1 ML Injection [SY] | 3 | 1 | Glycopyrrolate | 20251016 |
| 3edcc39d-0e29-4585-e063-6394a90ad512 | glycopyrrolate 0.2 MG in 1 ML Injection [PSN] · 1 ML glycopyrrolate 0.2 MG/ML Injection [SCD] · glycopyrrolate 0.2 MG per 1 ML Injection [SY] | 3 | 1 | Glycopyrrolate Injection, USP, R x only | 20250915 |
| 02f914a8-2356-4525-91ff-cf0c9e41ba23 | glycopyrrolate 0.2 MG in 1 ML Injection [PSN] · 1 ML glycopyrrolate 0.2 MG/ML Injection [SCD] · glycopyrrolate 0.2 MG per 1 ML Injection [SY] | 3 | 1 | Glycopyrrolate Injection, USP (For Intramuscular or Intravenous Use) | 20230112 |
| d9df3900-a8c2-438b-8971-ba11ff91f90b | glycopyrrolate 0.2 MG in 1 ML Injection [PSN] · 1 ML glycopyrrolate 0.2 MG/ML Injection [SCD] · glycopyrrolate 0.2 MG per 1 ML Injection [SY] | 3 | 1 | NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20220224 |
| a3eabc74-aded-4c1f-81dd-12b56c32703b | glycopyrrolate 0.2 MG in 1 ML Injection [PSN] · 1 ML glycopyrrolate 0.2 MG/ML Injection [SCD] · glycopyrrolate 0.2 MG per 1 ML Injection [SY] | 3 | 1 | GLYCOPYRROLATE injection, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL | 20210301 |